利用外部证据进行临床试验设计与贝叶斯分析:试验研究者观点的定性研究
该定性研究通过半结构化访谈16名试验研究者(13名统计学家和3名临床医生),探讨其在临床试验设计与贝叶斯分析中整合外部证据的态度与经验。结果显示,研究者虽在试验设计中以多种方式使用现有证据,但无人报告在贝叶斯框架下使用;主要障碍包括对外部数据相关性、贝叶斯方法可接受性、信心不足及数据获取困难等。
要点
- 试验研究者常以非正式方式利用现有证据进行试验设计,但样本中无人报告在贝叶斯框架下使用外部证据。
- 研究者多将贝叶斯分析等同于纳入干预效应的先验信息,较少意识到可纳入其他参数的数据。
- 实施障碍包括对外部数据相关性、贝叶斯方法可接受性与软件信心不足及数据获取困难。
核心结论
- 尽管试验研究者认识到在某些领域更正式地使用外部证据可能优于当前方法并可作为敏感性分析,但实践中仍存在障碍。
研究设计与样本
- 定性研究,采用半结构化访谈,共纳入16名试验研究者(13名统计学家和3名临床医生),通过滚雪球和目的抽样在英国多所大学和试验单位招募,采用主题分析和持续比较技术分析数据。
主要发现
- 试验研究者以多种方式在试验设计中使用现有证据,例如论证证据缺口和告知样本量计算中的参数。
- 样本中无人报告在贝叶斯框架下使用外部证据。
- 参与者倾向于将贝叶斯分析等同于纳入干预效应的先验信息,较少意识到可纳入其他参数的数据。
- 许多参与者在接触概念后认为,在特定场景下可更多利用现有数据来指导试验设计与分析。
- 识别出的实施障碍包括对外部数据相关性的担忧、贝叶斯方法的可接受性、对贝叶斯方法和软件缺乏信心以及获取相关数据的实际困难。
关键数值与推荐
- 原文未报告关键数值与推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence from previous studies is often used relatively informally in the design of clinical trials: for example, a systematic review to indicate whether a gap in the current evidence base justifies a new trial. External evidence can be used more formally in both trial design and analysis, by explicitly incorporating a synthesis of it in a Bayesian framework. However, it is unclear how common this is in practice or the extent to which it is considered controversial. In this qualitative study, we explored attitudes towards, and experiences of, trialists in incorporating synthesised external evidence through the Bayesian design or analysis of a trial. METHODS: Semi-structured interviews were conducted with 16 trialists: 13 statisticians and three clinicians. Participants were recruited across several universities and trials units in the United Kingdom using snowball and purposeful sampling. Data were analysed using thematic analysis and techniques of constant comparison. RESULTS: Trialists used existing evidence in many ways in trial design, for example, to justify a gap in the evidence base and inform parameters in sample size calculations. However, no one in our sample reported using such evidence in a Bayesian framework. Participants tended to equate Bayesian analysis with the incorporation of prior information on the intervention effect and were less aware of the potential to incorporate data on other parameters. When introduced to the concepts, many trialists felt they could be making more use of existing data to inform the design and analysis of a trial in particular scenarios. For example, some felt existing data could be used more formally to inform background adverse event rates, rather than relying on clinical opinion as to whether there are potential safety concerns. However, several barriers to implementing these methods in practice were identified, including concerns about the relevance of external data, acceptability of Bayesian methods, lack of confidence in Bayesian methods and software, and practical issues, such as difficulties accessing relevant data. CONCLUSIONS: Despite trialists recognising that more formal use of external evidence could be advantageous over current approaches in some areas and useful as sensitivity analyses, there are still barriers to such use in practice.
引用
- Clayton GL, Elliott D, Higgins JPT, et al. Use of external evidence for design and Bayesian analysis of clinical trials: a qualitative study of trialists' views. Trials. 2021. PMID: 34749778. doi:10.1186/s13063-021-05759-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。